US Food and Drug Administration (FDA)

General
Country: Americas > Northern America > United States of America
Policymaker type: Funder and research organisation
Policymaker name: US Food and Drug Administration (FDA)
Policymaker URL: http://www.fda.gov/
Policy adoption date: 22 August 2013
Source of policy: Administrative/management decision
Policy Terms
Deposit of item: Unspecified
Locus of deposit: Not Specified
Date of deposit: Not Specified
Content types specified under the mandate: Not Specified
Journal article version to be deposited: Not Specified
Can deposit be waived?: Not specified
Making deposited item Open Access: Not Mentioned
Can making the deposited item Open Access be waived?: Not Specified
Date deposit to be made Open Access: Not Mentioned
Other Details
Is deposit a precondition for research evaluation (the 'Liège/HEFCE Model')?: Not Specified
Rights holding: Not Mentioned
Can rights retention be waived?: Not Applicable
Can author waive giving permission to make the article Open Access?: Not specified
Policy's permitted embargo length for science, technology and medicine: Not Specified
Policy's permitted embargo length for humanities and social sciences: Not Specified
Can maximal allowable embargo length be waived?: Not Applicable
Open licensing conditions: Not specified
Gold OA publishing option: Not Specified
Funding for APCs where charged by journals: Not Mentioned

Added by (partner): EOS
URI: https://roarmap.eprints.org/id/eprint/523

Actions (login required)

View Item View Item